The announcement comes several days after a White House commission recommended the move.
President Donald Trump on Thursday said that he will declare a national emergency over the opioid epidemic.
“It’s a national emergency. We’re going to spend a lot of time, a lot of effort, and a lot of money on the opioid crisis,” Trump told reporters. “It is a serious problem, the likes of which we’ve never had. You know, when I was growing up, they had the LSD, and they had certain generations of drugs. There’s never been anything like what’s happened to this country over the last four or five years.”
The news comes just days after Trump administration officials, including Secretary of Health and Human Services Tom Price, suggested that Trump would not declare a national emergency. “We believe at this point that the resources we need or the focus that we need to bring to bear to the opioid crisis, at this point, can be addressed without the declaration of an emergency,” Price said, although he clarified that the option remains “on the table.”
It also comes more than a week after a White House commission on the drug crisis, led by New Jersey Gov. Chris Christie, in a preliminary report recommended the president declare the epidemic a national emergency. In 2016 alone, drug overdoses likely killed more Americans in one year than the entire Vietnam War. In 2015, drug overdoses topped annual deaths from car crashes, gun violence, and even HIV/AIDS during that epidemic’s peak in 1995.
“With approximately 142 Americans dying every day, America is enduring a death toll equal to September 11th every three weeks,” the commission’s report argues. “After September 11th, our President and our nation banded together to use every tool at our disposal to prevent any further American deaths. Your declaration would empower your cabinet to take bold steps and would force Congress to focus on funding and empowering the Executive Branch even further to deal with this loss of life.”
The declaration is supposed to empower the Trump administration to carry out the commission’s other recommendations. Among them:
Grant waiver approvals for all 50 states to eliminate existing regulatory barriers in the Medicaid program that exclude the federal Institutes for Mental Diseases. Under the Social Security Act, federal Medicaid funds can’t reimburse services from inpatient facilities that treat “mental diseases,” including addiction, with more than 16 beds. Eliminating this barrier would let states “immediately open treatment to thousands of Americans in existing facilities in all 50 states,” according to the commission.
Immediately set up and fund a federal program to improve access to medication-assisted treatment. This is the gold standard of opioid addiction treatment, with research showing that it can reduce the all-cause mortality rate among addiction patients by half or more. But it remains inaccessible; only 10 percent of conventional drug treatment facilities in the US provide medication-assisted treatment for opioid use disorder, according to the commission. The report wants this treatment greatly expanded, from health care settings in prison to traditional drug treatment facilities.
Better enforce federal law that requires health insurers to provide equal access to mental health services, including addiction. Health insurers often create onerous barriers to mental health care, seeing it as expensive. Federal law technically outlaws this for the plans that cover behavioral health, but the law remains poorly enforced. The report recommends that the federal government, particularly the secretary of labor, better enforce the law.
Expand access to the opioid overdose antidote naloxone. Among other plans, the commission vows to provide model legislation so states can allow the dispensing of naloxone through a standing order. Baltimore Health Commissioner Leana Wen used such legislation in 2015 to let anyone in the city carry naloxone; she estimates that it’s saved more than 950 people from overdose over the past two years.
Mandate education initiatives, with the help of medical schools and by amending the Controlled Substances Act, to require better training for prescribers about the treatment of pain and addiction. The opioid epidemic began when doctors prescribed an enormous amount of opioid painkillers, causing the drugs to proliferate across the country. By getting doctors to prescribe opioids more responsibly, the commission aims to pull back the original source of the current drug overdose crisis.
Provide federal support for state-based prescription drug monitoring programs. These programs, which all 50 states now have, let doctors closely watch a patient’s prescription drug history — letting them see if, say, a patient is shopping around to obtain as many opioids as possible from different doctors, or if a patient has a history of misusing drugs. But these programs often aren’t very robust and don’t share data across state lines, which federal aid could help address.
Fund more research for non-opioid painkillers. The current drug crisis began in part as doctors sought to tackle another major medical problem: 100 million US adults suffer from chronic pain. Despite the lack of evidence for opioids’ effectiveness in treating chronic pain, doctors often responded with opioids. By finding non-addictive, effective painkillers, the commission wants to give doctors a better, safer option.
Step up efforts to interdict fentanyl. As the opioid epidemic has progressed, many people suffering from opioid drug use disorder have moved from painkillers to heroin. More recently, though, much of this heroin has been laced with the even more potent opioid fentanyl — often without the knowledge of the people buying the heroin. This fentanyl is synthetically manufactured, and it often comes from around the world, such as clandestine labs in China. Among other proposals, the report asks for greater support for law enforcement and US Postal Service efforts — through more manpower and better technology, for example — to catch fentanyl as it’s transported.
The commission’s report addresses both sides of the opioid crisis: what Stanford drug policy expert Keith Humphreys has described to me as the “stock” and the “flow.” On one hand, you have the current stock of opioid users who are addicted; the people in this population need treatment or they will simply find other, potentially deadlier opioids to use if they lose access to painkillers. On the other hand, you have to stop new generations of potential drug users from accessing and misusing opioids.
A full response to the opioid epidemic would address both of these issues. It would take steps to prevent opioid misuse — by, for example, limiting access to painkillers while keeping them available to patients who truly need them. And it would greatly increase access to addiction care.
A lot of work remains to be done, particularly on the drug addiction treatment front. According to a 2016 report by the surgeon general, just 10 percent of Americans with a drug use disorder obtain specialty treatment. The report attributed the low rate to severe shortages in the supply of care, with some areas of the country, particularly rural counties, lacking affordable options for treatment — which can lead to waiting periods of weeks or even months.
Despite Trump’s looming declaration, it remains unclear whether he and Congress will act on the rest of the recommendations by the opioid commission.
So far, the White House and Congress have taken little action on this issue. The only major bill passed regarding the opioid epidemic added just $1 billion to drug treatment over two years — which is far from the tens of billions experts estimate is necessary.
Congress, with Trump’s support, has even worked against some of the commission’s recommendations by moving — unsuccessfully so far — to repeal Obamacare, which expanded access to addiction treatment through increased insurance coverage and regulations that require equal access to mental health services.
By acknowledging the crisis for what it is, though, Trump now has a chance to turn the page on this issue.